News | News By Subject | News by Disease News By Date | Search News

Anorexia Nervosa News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Helsinn Group Release: Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Shows Significant Increase In Lean Body Mass, Body Weight And Improved Symptoms     9/29/2014
Lightlake Therapeutics Inc. (LLTP) Announces Positive Preliminary Phase II Clinical Trial Results of Binge Eating Disorder Treatment     5/3/2012
Shire plc Reports Positive Phase 2 Study Met Primary End Point for Investigative Use of Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) in Adults With Binge Eating Disorder     4/26/2012
Par Pharmaceutical Companies, Inc. (PRX) Release: FDA Extends PDUFA Date For Megace(R) ES To July 29, 2005     4/18/2005
Rejuvenon Corp.'s RC-1291 Ghrelin Mimetic Receives Fast Track Designation From FDA For Cancer Anorexia/Cachexia     1/10/2005
FDA Accepts For Filing Par Pharmaceutical Companies, Inc.'s (PRX) NDA For Megestrol Acetate Oral Suspension NCD     9/16/2004

News from Around the Web
Obese Or Anorexic Individuals React Differently To Taste, University of Colorado Anschutz Study Says     5/17/2016
Brain Stimulation May Help Anorexics, King's College London Study     3/28/2016
About 30 Million Americans Suffer From Eating Disorders     2/22/2016
Gut Microbes Linked To Anorexia, University of North Carolina Study     10/7/2015
Money Problems Lead Women To Eating Disorders, University of Southampton Study     2/17/2015
For Anorexic Men, The Focus Is On Muscle, University Of Montreal Study     12/31/2014
Spring Babies Face Anorexia Risk, Oxford University Study Suggests     5/5/2011
Explosion of Steroid Use Fuelled By Reverse Anorexia, NHS Greater Glasgow and Clyde Study     1/27/2011
New CT Technology Shows Anorexia Impairs Adolescent Bone Development, Massachusetts General Hospital Study     11/18/2008
Womb Hormones "Leads to Anorexia"     12/4/2007
Anorexia Visible with Brain Scans     12/3/2007
Low Testosterone May Impair Mood in Anorexic Women     6/7/2007
Strong Right-Handedness Linked to Poor Body Image and Eating Disorders     4/13/2007
Genes Play Bigger Role Than Environment In Anorexia: Specialist     1/26/2007
Age No Barrier To Anorexia, Illness Afflicts Children     12/4/2006

Press Releases
Shire (SHPG) Announces Update To Vyvanse (Lisdexamfetamine Dimesylate) U.S. Labeling To Include New Longer-Term Maintenance Of Efficacy Data In Adults With Moderate To Severe Binge Eating Disorder     10/17/2016
Motus Presents Clinical Proof-Of-Concept Results For Relamorelin In The Treatment Of Anorexia     4/4/2016
Cannabics Pharmaceuticals Announces Start Of Clinical Study In Israel For Cancer Patients     3/22/2016
Helsinn Announces Publication Of Anamorelin ROMANA 1 And ROMANA 2 Phase III Studies In The Lancet     2/23/2016
Helsinn Announces European Medicines Agency Acceptance Of Marketing Authorization Application For Anamorelin HCL     11/30/2015
Helsinn Group Signs Exclusive Agreement With Bial For Distribution And Licence Of Anamorelin In Spain, Portugal, Angola And Mozambique     9/8/2015
Helsinn Group Signs Exclusive Agreement With Munipharma For The Distribution And Licence Of Anamorelin In Switzerland And Liechtenstein     9/3/2015
Shire plc Release: Vyvanse (lisdexamfetamine dimesylate) Positive Top-Line Results In Maintenance Of Efficacy Study In Adults With Moderate To Severe Binge Eating Disorder     7/22/2015
National Eating Disorder Information Centre Release: Research Suggests That Eating Disorders Are More Common Than Previously Thought     1/27/2015
Helsinn Group And Gen Ilac Establish A Collaboration For Anamorelin In Turkey     6/30/2014
Lightlake Therapeutics Inc. (LLTP) Announces Phase II Clinical Trial Results of Treatment for Binge Eating Disorder Accepted at the American Psychiatric Association Annual Meeting     3/27/2013
Eating Disorders in Teen ER Patients Suggests an Opportunity to Spot Hidden Problems, University of Michigan Health System Study Reveals     11/21/2012
The Hastings Center Release: Study of Women With Anorexia Nervosa Finds Inner Conflicts Over the "Real" Self that Have Treatment Implications     11/22/2011
Sapphire Therapeutics, Inc. to Present Results From Anamorelin Phase 2 Cachexia/Anorexia Studies at American Society of Clinical Oncology and Endocrine Society Annual Meetings in June     4/26/2007
Sapphire Therapeutics, Inc. Licenses Novel Drug To Ono Pharmaceutical Company, Ltd. In Japan, Korea And Taiwan For The Treatment Of Cancer Anorexia/Cachexia     10/26/2006

//-->